Gu J, Zheng M, Holden D, Fowles K, Qiu L, Felchner Z
Mol Imaging Biol. 2025; 27(1):54-63.
PMID: 39779653
DOI: 10.1007/s11307-024-01979-x.
Piel I, Constantinescu C, de la Puente Bethencourt D, Bonsall D, Rabiner E, Zasadny K
J Cereb Blood Flow Metab. 2024; :271678X241291949.
PMID: 39479946
PMC: 11563544.
DOI: 10.1177/0271678X241291949.
Cselenyi Z, Jucaite A, Ewing P, Stenkrona P, Kristensson C, Johnstrom P
Front Nucl Med. 2024; 2:1080005.
PMID: 39354985
PMC: 11440881.
DOI: 10.3389/fnume.2022.1080005.
Ridler K, Rizzo G, Burstein E, Forsberg Moren A, Stepanov V, Halldin C
J Cereb Blood Flow Metab. 2024; 45(2):352-364.
PMID: 39169749
PMC: 11800257.
DOI: 10.1177/0271678X241276312.
Nag S, Datta P, Forsberg Moren A, Khani Y, Martarello L, Kaliszczak M
Int J Mol Sci. 2024; 25(14).
PMID: 39063112
PMC: 11277166.
DOI: 10.3390/ijms25147870.
PET Imaging of Sphingosine-1-Phosphate Receptor 1 with [18F]TZ4877 in Nonhuman Primates.
Gu J, Zheng M, Holden D, Fowles K, Qiu L, Felchner Z
Res Sq. 2024; .
PMID: 38854065
PMC: 11160920.
DOI: 10.21203/rs.3.rs-4350862/v1.
DOCK-PET: database of CNS kinetic parameters in the healthy human brain for existing PET tracers.
Miyajima I, Yoshikawa A, Sahashi K, Seki C, Nagai Y, Watabe H
Ann Nucl Med. 2024; 38(8):666-672.
PMID: 38814564
DOI: 10.1007/s12149-024-01947-z.
Kinetic modeling of the monoamine oxidase-B radioligand [F]SMBT-1 in human brain with positron emission tomography.
Lopresti B, Stehouwer J, Reese A, Mason N, Royse S, Narendran R
J Cereb Blood Flow Metab. 2024; 44(11):1262-1276.
PMID: 38735059
PMC: 11542143.
DOI: 10.1177/0271678X241254679.
PET imaging of M4 muscarinic acetylcholine receptors in rhesus macaques using [C]MK-6884: Quantification with kinetic modeling and receptor occupancy by CVL-231 (emraclidine), a novel positive allosteric modulator.
Belov V, Guehl N, Duvvuri S, Iredale P, Moon S, Dhaynaut M
J Cereb Blood Flow Metab. 2024; 44(8):1329-1342.
PMID: 38477292
PMC: 11342722.
DOI: 10.1177/0271678X241238820.
Preliminary Assessment of Reference Region Quantification and Reduced Scanning Times for [F]SynVesT-1 PET in Parkinson's Disease.
Smart K, Uribe C, Desmond K, Martin S, Vasdev N, Strafella A
Mol Imaging. 2023; 2023:1855985.
PMID: 37622164
PMC: 10445483.
DOI: 10.1155/2023/1855985.
Clustering of KOR PET images separates people with AUD into distinct responses to naltrexone.
Hoye J, Key J, de Laat B, Cosgrove K, Krishnan-Sarin S, Papademetris X
Brain Imaging Behav. 2023; 17(3):367-371.
PMID: 36695971
PMC: 11815977.
DOI: 10.1007/s11682-023-00758-6.
Radiochemical Synthesis and Evaluation of 3-[C]Methyl-4-aminopyridine in Rodents and Nonhuman Primates for Imaging Potassium Channels in the CNS.
Sun Y, Guehl N, Zhou Y, Takahashi K, Belov V, Dhaynaut M
ACS Chem Neurosci. 2022; 13(23):3342-3351.
PMID: 36417797
PMC: 9732819.
DOI: 10.1021/acschemneuro.2c00364.
Meta-analysis of molecular imaging of translocator protein in major depression.
Eggerstorfer B, Kim J, Cumming P, Lanzenberger R, Gryglewski G
Front Mol Neurosci. 2022; 15:981442.
PMID: 36226319
PMC: 9549359.
DOI: 10.3389/fnmol.2022.981442.
and NIR fluorescence lifetime imaging with a time-gated SPAD camera.
Smith J, Rudkouskaya A, Gao S, Gupta J, Ulku A, Bruschini C
Optica. 2022; 9(5):532-544.
PMID: 35968259
PMC: 9368735.
DOI: 10.1364/OPTICA.454790.
Evaluation of ()-, ()-, and ()-F-OF-NB1 for Imaging GluN2B Subunit-Containing -Methyl-d-Aspartate Receptors in Nonhuman Primates.
Ahmed H, Zheng M, Smart K, Fang H, Zhang L, Emery P
J Nucl Med. 2022; 63(12):1912-1918.
PMID: 35710735
PMC: 9730915.
DOI: 10.2967/jnumed.122.263977.
Principal Component Analysis versus Subject's Residual Profile Analysis for Neuroinflammation Investigation in Parkinson Patients: A PET Brain Imaging Study.
Mabrouk R
J Imaging. 2022; 8(3).
PMID: 35324611
PMC: 8954189.
DOI: 10.3390/jimaging8030056.
Regional amyloid correlates of cognitive performance in ageing and mild cognitive impairment.
Stevens D, Workman C, Kuwabara H, Butters M, Savonenko A, Nassery N
Brain Commun. 2022; 4(1):fcac016.
PMID: 35233522
PMC: 8882008.
DOI: 10.1093/braincomms/fcac016.
Comparison of three novel radiotracers for GluN2B-containing NMDA receptors in non-human primates: -[C]NR2B-Me, -[F]of-Me-NB1, and -[F]of-NB1.
Smart K, Zheng M, Ahmed H, Fang H, Xu Y, Cai L
J Cereb Blood Flow Metab. 2022; 42(8):1398-1409.
PMID: 35209743
PMC: 9274863.
DOI: 10.1177/0271678X221084416.
Characterization in nonhuman primates of (R)-[F]OF-Me-NB1 and (S)-[F]OF-Me-NB1 for imaging the GluN2B subunits of the NMDA receptor.
Zheng M, Ahmed H, Smart K, Xu Y, Holden D, Kapinos M
Eur J Nucl Med Mol Imaging. 2022; 49(7):2153-2162.
PMID: 35107627
PMC: 9165293.
DOI: 10.1007/s00259-022-05698-9.
Validation and test-retest repeatability performance of parametric methods for [C]UCB-J PET.
Tuncel H, Boellaard R, Coomans E, Hollander-Meeuwsen M, de Vries E, Glaudemans A
EJNMMI Res. 2022; 12(1):3.
PMID: 35072802
PMC: 8786991.
DOI: 10.1186/s13550-021-00874-8.